Importantly, several studies about genomic landscape have validated that frequent disruption of MAPK signaling pathway, PI3K-Akt signaling pathway, cell cycle, wnt signaling pathway and MET were strongly involved in ESCC [12, 14, 47]. The gene discussed is MET; the disease is esophageal squamous cell carcinoma.